The association of perceived cannabis risks and benefits with cannabis use since cancer diagnosis.

Corinne McDaniels-Davidson, Humberto Parada, Nasim Kasiri, Sandip P Patel, David Strong, Neal Doran
{"title":"The association of perceived cannabis risks and benefits with cannabis use since cancer diagnosis.","authors":"Corinne McDaniels-Davidson, Humberto Parada, Nasim Kasiri, Sandip P Patel, David Strong, Neal Doran","doi":"10.1093/jncimonographs/lgad024","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Many patients with cancer use cannabis to help alleviate untreated cancer symptoms and side effects.</p><p><strong>Methods: </strong>We examined associations of perceived benefits and risks and postdiagnosis cannabis use in a weighted sample of adult cancer survivors through a 1-time survey. Fifteen perceived cannabis use benefits and 19 perceived risks were operationalized as both summary scores and report of any benefits or risks. Survey-weighted logistic regression provided covariate-adjusted odds of postdiagnosis cannabis use for each benefit-risk measure.</p><p><strong>Results: </strong>Among the weighted population of 3785 survivors (mean [SD] age = 62.2 [13.5] years), one-third used cannabis after diagnosis. Perceiving any benefits increased the odds of postdiagnosis cannabis use more than 500%, and perceiving any risks lowered the odds by 59%. Each SD increase in endorsed benefits doubled the odds of postdiagnosis cannabis use, while each SD increase in endorsed risks reduced the odds by 36%.</p><p><strong>Conclusion: </strong>An accurate understanding of benefits and risks is critical for informed decision making.</p>","PeriodicalId":73988,"journal":{"name":"Journal of the National Cancer Institute. Monographs","volume":"2024 66","pages":"244-251"},"PeriodicalIF":0.0000,"publicationDate":"2024-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11303868/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the National Cancer Institute. Monographs","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/jncimonographs/lgad024","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Many patients with cancer use cannabis to help alleviate untreated cancer symptoms and side effects.

Methods: We examined associations of perceived benefits and risks and postdiagnosis cannabis use in a weighted sample of adult cancer survivors through a 1-time survey. Fifteen perceived cannabis use benefits and 19 perceived risks were operationalized as both summary scores and report of any benefits or risks. Survey-weighted logistic regression provided covariate-adjusted odds of postdiagnosis cannabis use for each benefit-risk measure.

Results: Among the weighted population of 3785 survivors (mean [SD] age = 62.2 [13.5] years), one-third used cannabis after diagnosis. Perceiving any benefits increased the odds of postdiagnosis cannabis use more than 500%, and perceiving any risks lowered the odds by 59%. Each SD increase in endorsed benefits doubled the odds of postdiagnosis cannabis use, while each SD increase in endorsed risks reduced the odds by 36%.

Conclusion: An accurate understanding of benefits and risks is critical for informed decision making.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
感知到的大麻风险和益处与癌症确诊后使用大麻的关联。
背景:许多癌症患者使用大麻来帮助缓解未经治疗的癌症症状和副作用:许多癌症患者使用大麻来帮助缓解未经治疗的癌症症状和副作用:我们通过一次性调查,在成年癌症幸存者的加权样本中研究了感知到的益处和风险与确诊后使用大麻的关联。15 种感知到的使用大麻的益处和 19 种感知到的风险均以总分和对任何益处或风险的报告来表示。调查加权逻辑回归为每种益处-风险测量提供了经过协变量调整的确诊后使用大麻的几率:在 3785 名加权幸存者(平均 [SD] 年龄 = 62.2 [13.5] 岁)中,三分之一的人在确诊后使用大麻。认为有任何益处的幸存者在确诊后使用大麻的几率增加了 500% 以上,而认为有任何风险的幸存者使用大麻的几率降低了 59%。认可的益处每增加一个标准差,诊断后使用大麻的几率就会增加一倍,而认可的风险每增加一个标准差,几率就会降低 36%:结论:准确了解益处和风险对于做出知情决策至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
6.30
自引率
0.00%
发文量
0
期刊最新文献
Challenges to and considerations of designing cancer prevention trials. Design and analysis considerations for investigating patient subgroups of interest within cancer clinical trials. Design considerations and challenges in the CHinA National CancEr Screening (CHANCES) trial and Tomosynthesis Mammographic Imaging Screening Trial (TMIST). Global perspectives on patient-centered outcomes: advancing patient-centered cancer clinical trials globally. Intracluster correlation coefficients from cluster randomized trials conducted within the NCI Community Oncology Research Program (NCORP).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1